FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

770963001: Ibalizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3703617011 Ibalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3703618018 Ibalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3703617011 Ibalizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3703618018 Ibalizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibalizumab (substance) Is a Substance with antiretroviral mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Ibalizumab (substance) Has disposition Human immunodeficiency virus entry inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Ibalizumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Ibalizumab (substance) Is a Substance with human immunodeficiency virus entry inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ibalizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ibalizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only ibalizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only ibalizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibalizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start